Developed by our strategic partner Guangzhou Advanced Regenerative Medicine, sets a new benchmark in skin science by overcoming long-standing challenges in elastin research
1. Dual innovation for superior efficacy:
- Structural Precision: Proprietary β-spiral folding technology mimics natural elastin’s biomechanical properties (100% sequence identity), enabling seamless integration with skin tissue.
- Medical-Grade Safety: Achieves 98% purity and <0.01 EU/mL endotoxins—surpassing industry standards for biocompatibility and safety.
- Instant & Long-Term Results: Clinically proven to deliver immediate lifting and 14.74% hydration boost within 14 days, while stimulating fibroblast activity to rebuild collagen/elastin networks for sustained firmness and wrinkle reduction.
2. Long-acting patent tech: Solving transdermal absorption challenges
Arelastin®’s efficacy hinges on its ADI Multi-Dimensional Transdermal Technology, a patented system that shatters skin barrier limitations:
90% Penetration Efficiency: Proprietary ADI transdermal tech achieves 90% absorption, delivering Arelastin® to the dermis for direct elastin replenishment. Clinically validated via fluorescence imaging (1-hour post-application).
Formulation Resilience: Maintains stability across tested temperatures (-17.5°C to 45°C) and pH fluctuations, with proven compatibility in serums, creams, and medical-grade dermal implants.
Why it matters:
Traditional elastin replacements fail due to poor absorption and structural inaccuracy. Arelastin®’s dual innovation—structural biomimicry + transdermal mastery—powers its role in aesthetic medicine as a “non-surgical facelift” and scar-free healing solution, while offering brands a sustainable, high-performance anti-aging pillar.
Uniproma is committed to introducing cutting-edge innovations to meet the growing demand for more effective, greener, and sustainable solutions. We invite you to harness this scientific milestone—where cutting-edge biology meets timeless beauty.
